NCT06201507 BV-AVD-R Treatment Children Hodgkin's Lymphoma Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06176690 Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas Status RECRUITING Phase PHASE1
NCT06170489 A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL) Status RECRUITING Phase PHASE3
NCT06150664 A Phase 1 of CTX-8371 in Patients With Advanced Malignancies Status RECRUITING Phase PHASE1
NCT06137144 AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies. Status RECRUITING Phase PHASE1/PHASE2
NCT06131801 Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution Status RECRUITING Phase N/A
NCT06104878 A Study in Adults With Advanced Classical Hodgkin's Lymphoma (cHL) in Brazil Treated With Brentuximab Vedotin Together With Chemotherapy Compared to Chemotherapy Alone Status WITHDRAWN Phase N/A
NCT06090864 ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells Status RECRUITING Phase PHASE1/PHASE2
NCT06059391 CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT06045195 Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06002828 Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors Status RECRUITING Phase N/A
NCT05977673 Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy Status RECRUITING Phase PHASE2
NCT05974410 Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Status AVAILABLE Phase N/A
NCT05972577 Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study Status COMPLETED Phase NA
NCT05922904 PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05871008 Integrated Actionable Aging Assessment for Cancer Patients Pilot Status ACTIVE_NOT_RECRUITING Phase NA
NCT05840575 Investigating Cognitive Impairment in Young Patients With Cancer Prospectively Status RECRUITING Phase N/A
NCT05839210 Lifestyle Intervention of Food and Exercise for Lymphoma Survivors Status RECRUITING Phase NA
NCT05798897 Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma Status RECRUITING Phase PHASE1